Literature DB >> 11673568

Transplacental genetic immunization after intravenous delivery of plasmid DNA to pregnant mice.

K Okuda1, K Q Xin, A Haruki, S Kawamoto, Y Kojima, F Hirahara, H Okada, D Klinman, K Hamajima.   

Abstract

A number of factors influence the development of tolerance, including the nature, concentration, and mode of Ag presentation to the immune system, as well as the age of the host. The studies were conducted to determine whether immunizing pregnant mice with liposome-encapsulated DNA vaccines had an effect on the immune status of their offspring. Two different plasmids (encoding Ags from HIV-1 and influenza virus) were administered i.v. to pregnant mice. We examined the uptake of plasmid DNA by the fetuses until the 21st postcoital day, but little such transfer occurred in early pregnancy. At 9.5 days postconception with cationic liposomes, injected plasmid was present in the tissues of the fetus, consistent with transplacental transfer. When the offspring of vaccinated dams were immunized with DNA vaccine, they mounted stronger Ag-specific immune responses than controls, and were protected against challenge by homologous influenza virus after vaccination. Moreover, such immune responses were strong in the offspring of mothers injected with DNA plasmid 9.5 days after coitus. These results suggest that DNA-vaccinated mothers confer the Ag-specific immunity to their progeny.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673568     DOI: 10.4049/jimmunol.167.9.5478

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model.

Authors:  Ronald B Moss; Jay R Savary; Jocelyn P Diveley; Fred Jensen; Dennis J Carlo
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

3.  Maternal LAMP/p55gagHIV-1 DNA immunization induces in utero priming and a long-lasting immune response in vaccinated neonates.

Authors:  Paula Ordonhez Rigato; Milton Maciel; Adriana Letícia Goldoni; Orlando Guerra Piubelli; Noemia Mie Orii; Ernesto Torres Marques; Joseph Thomas August; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

4.  Transplacental RNAi: deciphering gene function in the postimplantation-staged embryo.

Authors:  K Sue O'shea; Lisa S De Boer; Nicole A Slawny; Theresa E Gratsch
Journal:  J Biomed Biotechnol       Date:  2006

Review 5.  Transplacental Gene Delivery (TPGD) as a Noninvasive Tool for Fetal Gene Manipulation in Mice.

Authors:  Shingo Nakamura; Satoshi Watanabe; Naoko Ando; Masayuki Ishihara; Masahiro Sato
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

6.  Detection of Progeny Immune Responses after Intravenous Administration of DNA Vaccine to Pregnant Mice.

Authors:  Ke-Qin Xin; Shin Sasaki; Yoshitsugu Kojima; Nao Jounai; Yasuko Kumamoto; Kumiko Hashimoto; Kaori Shinoda; Kenji Hamajima; Kenji Okuda
Journal:  Biol Proced Online       Date:  2002-04-23       Impact factor: 3.244

Review 7.  Recent Developments in Preclinical DNA Vaccination.

Authors:  Kenji Okuda; Yoshiyuki Wada; Masaru Shimada
Journal:  Vaccines (Basel)       Date:  2014-01-13

8.  Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.

Authors:  Ting Huang; Xuhao Song; Jie Jing; Kelei Zhao; Yongmei Shen; Xiuyue Zhang; Bisong Yue
Journal:  J Nanobiotechnology       Date:  2018-01-29       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.